NCT06615401

Brief Summary

Transgender Veterans (trans Vets) frequently experience gender dysphoria or distress related to discord between their gender identity and birth sex. Gender-affirming treatments (GATs) are medically necessary treatments to reduce gender dysphoria. However, not much is known about the barriers and facilitators that influence GAT access and receipt in VA and VA Community Care (CC), among trans Vets who desire GATs. The goals of this mixed-methods study are to determine which GATs trans Vets receive and in which setting, identify barriers and facilitators associated with desired GAT receipt in VA and CC, examine association of GAT receipt, specifically mental healthcare and hormone therapy, with mental health and suicide risk and understand trans Vet experiences related to receipt and desire for mental healthcare and hormone therapy in VA and CC.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
986

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 23, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 26, 2024

Completed
5 days until next milestone

Study Start

First participant enrolled

October 1, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 18, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 18, 2025

Completed
1 year until next milestone

Results Posted

Study results publicly available

January 28, 2026

Completed
Last Updated

January 28, 2026

Status Verified

January 1, 2026

Enrollment Period

4 months

First QC Date

September 23, 2024

Results QC Date

January 13, 2026

Last Update Submit

January 13, 2026

Conditions

Keywords

transgendergender dysphoriagender-affirming treatment

Outcome Measures

Primary Outcomes (1)

  • Receipt of Gender Affirming Treatment

    Through a national survey, the investigators will identify receipt of gender-affirming treatment in VA and VA Community Care among transgender and gender diverse Veterans.

    About 3.5 months

Study Arms (1)

Transgender and Gender Diverse Veterans

Veterans with documentation of either a gender identity disorder diagnoses, self-identified gender identity as transgender and gender diverse or transgender-related health factor.

Eligibility Criteria

Sexall(Gender-based eligibility)
Gender Eligibility DetailsAll transmasculine, transfeminine and non-binary Veterans identified by the inclusion criteria above.
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Transgender and gender diverse veterans as identified by documentation of gender identity disorder diagnoses, self-identified gender identity and transgender-related health factors.

You may qualify if:

  • All veterans with documentation of gender identity disorder diagnoses
  • Self-reported gender identity as transgender and relevant transgender-related health factor

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VA Bedford HealthCare System, Bedford, MA

Bedford, Massachusetts, 01730-1114, United States

Location

Related Publications (1)

  • Jasuja GK, Zocchi MS, Reisman JI, Brady JE, Livingston NA, Blosnich JR, Vimalananda VG, Singh RS, Goodman M, Silverberg MJ, Wormwood JB, Shipherd JC. Using Self-Identified Gender Identity Data to Advance Health Equity Among Transgender and Gender Diverse Veterans in the Veterans Health Administration. Med Care. 2025 Nov 1;63(11):833-841. doi: 10.1097/MLR.0000000000002195. Epub 2025 Sep 26.

MeSH Terms

Conditions

Gender Dysphoria

Condition Hierarchy (Ancestors)

Sexual Dysfunctions, PsychologicalMental Disorders

Results Point of Contact

Title
Guneet Jasuja
Organization
VA Bedford Healthcare System

Study Officials

  • Guneet K. Jasuja, PhD

    VA Bedford HealthCare System, Bedford, MA

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 23, 2024

First Posted

September 26, 2024

Study Start

October 1, 2024

Primary Completion

January 18, 2025

Study Completion

January 18, 2025

Last Updated

January 28, 2026

Results First Posted

January 28, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations